Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125353571 | 12535357 | 1 | I | 20160622 | 20160707 | 20160707 | EXP | CZ-ACCORD-042109 | ACCORD | MRAZOVA, I. BEVACIZUMAB IN TREATMENT OF METASTATIC BREAST CANCER. ACTA MEDICINAE, NO. 3/2016, P. 30-33. | 0.00 | F | Y | 0.00000 | 20160707 | MD | CZ | CZ |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125353571 | 12535357 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Oral | 202593 | |||||||||||
| 125353571 | 12535357 | 2 | SS | PACLITAXEL/PACLITAXEL LIPOSOME | PACLITAXEL | 1 | JAN-MAR-2011, 5TH, 6TH, 7TH SERIES OF PACLITAXEL | U | 75436 | ||||||||||
| 125353571 | 12535357 | 3 | C | AVASTIN | BEVACIZUMAB | 1 | 1-MAR-2012, AT 15 MG/KG, APR AND OCT-2012, 5-8/2012 AT 15 MG/KG, SEP-2012 AT SAME DOSE | 0 | |||||||||||
| 125353571 | 12535357 | 4 | C | HERCEPTIN | TRASTUZUMAB | 1 | 0 | Q3W | |||||||||||
| 125353571 | 12535357 | 5 | C | BONDRONAT | IBANDRONIC ACID | 1 | Intravenous (not otherwise specified) | SUBSEQUENTLY WITHDRAWN AFTERWARDS | 0 | ||||||||||
| 125353571 | 12535357 | 6 | C | FASLODEX | FULVESTRANT | 1 | Subcutaneous | ONCE IN 28 DAYS | 0 | 500 | MG | ||||||||
| 125353571 | 12535357 | 7 | C | FEMARA | LETROZOLE | 1 | 0 | TABLET | |||||||||||
| 125353571 | 12535357 | 8 | C | XGEVA | DENOSUMAB | 1 | THAN ON OCT-2013 AND ON NOV-2013 IT WAS DISCONTINUED | 0 | |||||||||||
| 125353571 | 12535357 | 9 | C | ZOMETA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 125353571 | 12535357 | 10 | C | TAMOXIFEN/TAMOXIFEN CITRATE | 2 | 0 | TABLET | ||||||||||||
| 125353571 | 12535357 | 11 | C | MEGAPLEX | 2 | 0 | TABLET | ||||||||||||
| 125353571 | 12535357 | 12 | C | NAVELBINE | VINORELBINE TARTRATE | 1 | Intravenous (not otherwise specified) | NOV-2013 23RD APPLICATIONS AND THAN SUBSEQUENTLY WITHDRAWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125353571 | 12535357 | 1 | Breast cancer |
| 125353571 | 12535357 | 2 | Breast cancer |
| 125353571 | 12535357 | 3 | Breast cancer metastatic |
| 125353571 | 12535357 | 4 | Breast cancer |
| 125353571 | 12535357 | 5 | Breast cancer |
| 125353571 | 12535357 | 6 | Back pain |
| 125353571 | 12535357 | 7 | Arthralgia |
| 125353571 | 12535357 | 8 | Breast cancer |
| 125353571 | 12535357 | 9 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125353571 | 12535357 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125353571 | 12535357 | Neurotoxicity | |
| 125353571 | 12535357 | Off label use | |
| 125353571 | 12535357 | Palmar-plantar erythrodysaesthesia syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125353571 | 12535357 | 1 | 201204 | 201209 | 0 | |
| 125353571 | 12535357 | 2 | 201101 | 201103 | 0 | |
| 125353571 | 12535357 | 3 | 201304 | 0 | ||
| 125353571 | 12535357 | 4 | 201008 | 0 | ||
| 125353571 | 12535357 | 5 | 20120301 | 0 | ||
| 125353571 | 12535357 | 6 | 201109 | 0 | ||
| 125353571 | 12535357 | 7 | 201104 | 201108 | 0 | |
| 125353571 | 12535357 | 8 | 201311 | 201311 | 0 | |
| 125353571 | 12535357 | 9 | 201204 | 201301 | 0 | |
| 125353571 | 12535357 | 10 | 200707 | 0 | ||
| 125353571 | 12535357 | 11 | 201211 | 201212 | 0 | |
| 125353571 | 12535357 | 12 | 201304 | 0 |